Porter, Richard H. P. et al
"Fenobam: A Clinically Validated Nonbenzodiazepine Anxiolytic Is a Potent, Selective, and Noncompetitive mGlu5 Receptor Antagonist with Inverse Agonist Activity." Journal of Pharmacology and Experimental Therapeutics
315.2
(2005):
711-721.
Web. 28 Dec. 2024.
